1.732
price down icon0.46%   -0.008
 
loading

Finanzdaten der Edesa Biotech Inc-Aktie (EDSA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-30 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
93.90%
0.9391
0.4843 1.0198 0.1039 0.8973
Operating Income/Loss
16.16%
-1.9037
-1.6389 -1.8987 -1.0044 -1.9324
Nonoperating Income/Loss
213.33%
0.1543
0.0492 0.2814 0.0423 0.2642
Income/Loss From Continuing Operations Before Tax
10.05%
-1.7495
-1.5896 -1.6173 -0.9621 -1.6682
Income Tax Expense/Benefit
100.00%
-
0.0008 - - -
Income/Loss From Continuing Operations After Tax
10.00%
-1.7495
-1.5904 -1.6173 -0.9621 -1.6682
Net Income/Loss
10.00%
-1.7495
-1.5904 -1.6173 -0.9621 -1.6682
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
32.36%
7.0227
5.3058 -0.9911 0.0168 3.2218
Basic Earnings Per Share
16.67%
-0.25
-0.30 -0.44 -0.29 -0.52
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.66
price up icon 0.94%
$29.19
price up icon 1.29%
$101.70
price up icon 0.06%
$104.06
price up icon 0.25%
biotechnology ONC
$312.24
price down icon 0.17%
$187.13
price down icon 0.19%
Kapitalisierung:     |  Volumen (24h):